Cantú-Quintanilla G, Ubiarco V, Medeiros M, Gracida C, Reyes-Acevedo R, Reyes-López A, Alberú J

Language: Spanish
References: 17
Page: 91-95
PDF size: 189.79 Kb.

ABSTRACT

Introduction: The Mexico City Living Will (LVA), enacted on January 7, 2008, has the objective of setting forth and regulating norms and requirements of any person’s will regarding refusal to undergo treatments intended to unnecessarily prolong the person’s life. The person’s dignity is protected at all times, when for medical reasons it becomes impossible to maintain life in a natural way. This law does not permit or gives the authority, under any circumstances, to carry out acts having as a consequence the intentional abbreviation of life. Furthermore, the Law requires, in its Article 8, the expression regarding availability of organs susceptible of donation. A survey was applied at three socioeconomic levels of the general population regarding knowledge about LVA, with the following results: 64% of respondents do not know LVA. Out of respondents who do have a knowledge about LVA (n = 100), only 43% know about expressing oneself regarding organ donation. Regardless of knowledge about the Law, 68% of the total of respondents has the intention of donating their organs for transplant purposes. Given the scarcity of organs for transplantation, does the scientific community involved in transplants know about what such law sets forth? Objective: Documenting knowledge about and diffusion given to LVA, regarding transplants and their bioethical implications within the medical community involved in transplants. Material and methods: A survey was prepared to be applied during the XV Congress of the Mexican Transplant Society (Sociedad Mexicana de Trasplantes) in November, 2011. One hundred of the attendants to one of the plenary sessions of the Congress were invited to take part in the survey. Such survey included 16 questions regarding their belonging to an internal Transplant Committee, their knowledge about the Law, the willingness to write the Living Will documentl, their intention to donate organs as per the Mexico City Living Will Law (LVA), the relationship with the Law, the expression of such intention, among others. Results: 78 replied questionnaires were received. 54% of respondents are part of an internal Transplant Committee; Out of total respondants, 58% do not know the LVA. Among personnel involved in transplants who do know the Law (n = 38), only 68% have a knowledge about what is set forth related to organ donation for transplant. Independently, 90% of respondents have the intention of donating their organs. Conclusion: The need is obvious of spreading the knowledge about LVA, both among general population and among health and transplant personnel is evident.

REFERENCES

1. Yepes R. Fundamentos de Antropología. Barañain EUNSA. 1996, pp. 297-324.

2. Llano A. Humanismo Cívico. Barcelona. Ariel. 1999, pp. 15-30.

3. Llano C. Los fantasmas de la sociedad contemporánea. México, Trillas. 1995, pp. 11-24.

4. Ley de Voluntad Anticipada para el Distrito Federal. Gaceta Oficial del Distrito Federal. 7 de Enero de 2008.

5. Reglamento de la ley de voluntad anticipada para el Distrito Federal. (2008) Gaceta Oficial del Distrito Federal. 4 de Abril 2008.

6. Cantú-Quintanilla G, Ubiarco V, Medeiros-Domingo M, Gracida-Juárez C, Reyes-Acevedo R, Reyes-López A y cols. La ley de voluntad anticipada del Distrito Federal, los trasplantes e ideología. Persona y Bioética. 2012; 16 (1): 11-17.

7. Serrano Ruiz-Calderón JM. Bioética, política y derecho. En: Tomás y Garrido, Postigo Solana, editoras. Bioética personalista: ciencia y controversias, Madrid, Ediciones Internacionales Universitarias. 2007, pp. 107-128.

8. Kemp P. La mundialización de la ética. México. Fontarama. 2007, pp. 89-106.

9. Rodríguez-Ortega G. Bioética, legislación, políticas públicas y derechos humanos, 2004 México. Comisión Nacional de Derechos Humanos. 2004, pp. 11-24.

10. García RS. Bioética y Derecho en Bioética, legislación, políticas públicas y derechos humanos, 2004 México. Comisión Nacional de Derechos Humanos. 2004, pp. 65-80.

11. Amato D, Alvarez AC, Castaneda LR, Rodriguez E, Avila DM, Arreola F et al. Prevalence of chronic kidney disease in an urban Mexican population. Kidney Int Suppl. 2005; (97): S11-17.

12. Obrador GT, Garcia GG, Villa AR, Rubilar X, Olvera N, Ferreira E et al. Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) Mexico and comparison with KEEP US. Kidney Int Suppl. 2010; (116): S2-8.

13. Franco MF, Tirado GL, Venado Estrada A, Moreno LJ, Pacheco DR, Duran AJ y cols. Una estimación indirecta de las desigualdades actuales y futuras en la frecuencia de la enfermedad renal crónica terminal en México. Salud Pública México. 2011; 53 (4): s506-s515.

14. López CM, Rojas RM, Tirado GL, Durán AJ, Pacheco DR, Venado EA y cols. Enfermedad renal crónica y su atención mediante tratamiento sustitutivo en México. México, D.F.: Facultad de Medicina-Universidad Nacional Autónoma de México, 2009.

15. CENATRA. Estadísticas. ¿Cuántas personas requieren recibir un trasplante?: Centro Nacional de Trasplantes. Accesado en 29 de Enero de 2012. Disponible en: http://www.cenatra.salud.gob.mx/interior/trasplante_estadisticas.html

16. Lamb KE, Lodhi S, Meier-Kriesche HU. Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant. 2011; 11 (3): 450-462.

17. Disponible en: www.stalyc.net.